BCG vaccine extensively used even in countries where efficacy against pulmonary tuberculosis is negligible. A number of possible reasons for the variable efficacy of BCG in different countries have been proposed. None have been proven, some have been disproved, and none can explain the lack of efficacy in both low-TB burden countries (US) and high-TB burden countries (India). The reasons for variable efficacy have been discussed at length in a WHO document on BCG. BCG has protective effects against some non-tuberculosis mycobacteria. BCG has been one of the most successful immunotherapies. BCG vaccine has been the "standard of care for patients with
Inoculation theory (1995) posited that the use of inoculation strategies for these types of campaigns should be utilized to enhance the corporations' credibility and aide in maintaining the existing consumer attitude. This strategy should not be used to change consumer attitudes. Based on the analysis of previous research Burgoon et al. concluded issue/advocacy advertising is most effective for reinforcing support and avoid potential slippage in the attitudes of supporters. Based on previous publications they looked to test three hypotheses. The first was that issue/advocacy advertisements work to inoculate against counterattitudinal attacks. Next, issue/advocacy advertisements work to protect the source credibility. Lastly, conservatives